VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

CHINO HILLS, CA / ACCESS Newswire / April 10, 2025 / SOHM, Inc. , a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is thrilled to announce and share ...

Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Cell and gene therapy manufacturers that adopt automated bioprocessing technologies are likely to use AI in QA/QC and batch release.

Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without ...

The pharmaceutical company says it will continue to operate its production facility near Research Triangle Park.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

The firm is hoping that the CRISPR/Cas9-edited TILs will have anti-tumor activity with long-term persistence against various solid tumors.

Oxford Biomedica plc ( OTCPK:OXBDF) Q4 2024 Earnings Conference Call April 9, 2025 8:00 AM ET Frank Mathias - Chief Executive Officer Sebastien Ribault - Chief Business Officer Lucy Crabtree - Chief ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...